CSP594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat
Status:
Completed
Trial end date:
2021-04-15
Target enrollment:
Participant gender:
Summary
This trial will compare two effective therapies, allopurinol and febuxostat, to lower serum
uric acid and therefore prevent further gout attacks. These therapies have never been
compared at appropriate doses. Further, they will be studied in patients with kidney disease
for the first time.